Evidence map›Paper›PMID 40119244›Full record

ArticleDigestive diseases and sciences2025

Evaluating New Non-invasive Screening Tests for Colorectal Cancer: An In-Depth International Perspective-Introduction to a Special Issue of Digestive Diseases and Sciences.

Robert S Bresalier, Graeme P Young, Carlo Senore

Abstract read
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Robert S BresalierDepartment of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard Unit 1466, Houston, TX, 77030, USA. rbresali@mdanderson.org.
Graeme P YoungFlinders Cancer Research, Flinders University Adelaide, Adelaide, SA, Australia.
Carlo SenoreUniversity Hospital Citta Della Salute e Della Sciencia, Turin, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is a global disease accounting for nearly one in 10 cancer cases and deaths which can be reduced through CRC screening. In 2023 the World Endoscopy Organization (WEO) set forth twelve newly stated principles whereby new non-invasive CRC screening tests could be efficiently evaluated by a rigorous phased comparative approach. The complexities of evaluating new and evolving CRC screening tests and the necessity for a "one size does not fit all" approach was stressed. This special issue of Digestive Diseases and Sciences expands on this document and provides in-depth discussions of several of the issues raised during its development from a global perspective.

Indexed as

Colorectal NeoplasmsEarly Detection of CancerMass ScreeningHumansOccult BloodCancer preventionColonoscopyColorectal cancer screening

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.